Pricing

Taysha Gene Therapies, Inc. (TSHA)

followers · 1 like
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO: R. A. Session
Employees: 180
Web site: tayshagtx.com
3000 PEGASUS PARK DRIVE, SUITE 1430, DALLAS, TX, 75247
(214) 612-0000
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Taysha Gene Therapies, Inc. focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company was incorporated in 2019 and is based in Dallas, Texas.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available